Drdgold annual ebitda
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Drdgold's calculated EBITDA was R6.46B for fiscal 2026.
View full Drdgold company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | R6.46B | R3.08B | +91.35% |
| 2025 | 2025-06-30 | R3.38B | R1.49B | +79.29% |
| 2024 | 2024-06-30 | R1.88B | R242.6M | +14.79% |
| 2023 | 2023-06-30 | R1.64B | R65.6M | +4.17% |
| 2022 | 2022-06-30 | R1.57B | −R494.7M | −23.91% |
| 2021 | 2021-06-30 | R2.07B | R860.7M | +71.21% |
| 2020 | 2020-06-30 | R1.21B | R914.4M | +310.70% |
| 2019 | 2019-06-30 | R294.3M | R74.3M | +33.77% |
| 2018 | 2018-06-30 | R220.0M | R64.7M | +41.66% |
| 2017 | 2017-06-30 | R155.3M | −R144.5M | −48.20% |
| 2016 | 2016-06-30 | R299.8M | — | — |
Over the last five fiscal years, Drdgold's ebitda increased from R2.07B to R6.46B, a change of R4.39B.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Drdgold source filings ↗